ALMOOSA

Almoosa Health Co.

4018StocksTadawulHealthcare

Financials

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	6.07B	7.77B	—	—	—
Enterprise Value	6.91B	8.38B	—	—	—
Last Close Price	137.10	175.40	—	—	—
Valuation Multiples
Forward PE (Next 12M Est.)	19.52	27.28	—	—	—
PE Ratio	30.47	38.78	—	—	—
PEG Ratio	0.50	0.70	—	—	—
PS Ratio	4.29	5.49	—	—	—
PB Ratio	3.07	3.93	—	—	—
P/TBV Ratio	3.08	3.95	—	—	—
P/FCF Ratio	—	36.88	—	—	—
P/OCF Ratio	28.83	36.88	—	—	—
EV/Sales Ratio	4.88	5.92	—	—	—
EV/EBITDA Ratio	22.68	27.57	—	—	—
EV/EBIT Ratio	31.40	38.20	—	—	—
EV/FCF Ratio	—	39.79	—	—	—
Leverage & Capital
Debt / Equity Ratio	0.44	0.44	1.89	1.86	1.23
Debt / EBITDA Ratio	2.87	2.87	5.13	6.46	7.07
Debt / FCF Ratio	4.14	4.14	—	—	—
Net Debt / Equity Ratio	0.42	0.42	1.83	1.83	1.20
Net Debt / EBITDA Ratio	2.74	2.74	5.12	6.58	7.40
Net Debt / FCF Ratio	3.96	3.96	-23.21	-3.51	-2.45
Efficiency & Liquidity
Asset Turnover	0.48	0.48	0.50	0.47	0.48
Inventory Turnover	—	—	13.07	12.33	11.76
Quick Ratio	0.08	0.08	0.93	0.95	0.82
Current Ratio	1.83	1.83	1.11	1.12	0.99
Returns & Yields
Return on Equity (ROE)	+14.9%	+14.9%	+13.7%	+15.1%	+8.2%
Return on Assets (ROA)	+4.7%	+4.7%	+4.7%	+3.8%	+2.1%
Return on Invested Capital (ROIC)	+8.0%	+8.9%	+8.6%	+7.3%	+4.1%
Return on Capital Employed (ROCE)	+7.7%	+7.7%	+9.1%	+6.8%	+3.9%
Earnings Yield	+3.3%	+2.6%	—	—	—
FCF Yield	—	+2.7%	—	—	—
Dividend Yield	+1.0%	+0.7%	—	—	—
Payout Ratio	—	—	+14.8%	—	—
Buyback Yield / Dilution	-27.2%	-27.2%	—	—	-34,900.0%
Total Shareholder Return	-26.2%	-26.5%	—	—	-34,900.0%

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	6.07B	7.77B	—	—	—
Enterprise Value	6.91B	8.38B	—	—	—
Last Close Price	137.10	175.40	—	—	—
Valuation Multiples
Forward PE (Next 12M Est.)	19.52	27.28	—	—	—
PE Ratio	30.47	38.78	—	—	—
PEG Ratio	0.50	0.70	—	—	—
PS Ratio	4.29	5.49	—	—	—
PB Ratio	3.07	3.93	—	—	—
P/TBV Ratio	3.08	3.95	—	—	—
P/FCF Ratio	—	36.88	—	—	—
P/OCF Ratio	28.83	36.88	—	—	—
EV/Sales Ratio	4.88	5.92	—	—	—
EV/EBITDA Ratio	22.68	27.57	—	—	—
EV/EBIT Ratio	31.40	38.20	—	—	—
EV/FCF Ratio	—	39.79	—	—	—
Leverage & Capital
Debt / Equity Ratio	0.44	0.44	1.89	1.86	1.23
Debt / EBITDA Ratio	2.87	2.87	5.13	6.46	7.07
Debt / FCF Ratio	4.14	4.14	—	—	—
Net Debt / Equity Ratio	0.42	0.42	1.83	1.83	1.20
Net Debt / EBITDA Ratio	2.74	2.74	5.12	6.58	7.40
Net Debt / FCF Ratio	3.96	3.96	-23.21	-3.51	-2.45
Efficiency & Liquidity
Asset Turnover	0.48	0.48	0.50	0.47	0.48
Inventory Turnover	—	—	13.07	12.33	11.76
Quick Ratio	0.08	0.08	0.93	0.95	0.82
Current Ratio	1.83	1.83	1.11	1.12	0.99
Returns & Yields
Return on Equity (ROE)	+14.9%	+14.9%	+13.7%	+15.1%	+8.2%
Return on Assets (ROA)	+4.7%	+4.7%	+4.7%	+3.8%	+2.1%
Return on Invested Capital (ROIC)	+8.0%	+8.9%	+8.6%	+7.3%	+4.1%
Return on Capital Employed (ROCE)	+7.7%	+7.7%	+9.1%	+6.8%	+3.9%
Earnings Yield	+3.3%	+2.6%	—	—	—
FCF Yield	—	+2.7%	—	—	—
Dividend Yield	+1.0%	+0.7%	—	—	—
Payout Ratio	—	—	+14.8%	—	—
Buyback Yield / Dilution	-27.2%	-27.2%	—	—	-34,900.0%
Total Shareholder Return	-26.2%	-26.5%	—	—	-34,900.0%